BamSEC and AlphaSense Join Forces
Learn More

Mersana Therapeutics Inc.

NASDAQ: MRSN    
Share price (1/7/25): $1.37    
Market cap (1/7/25): $169 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 5 pages Fifth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 19 pages Mersana Therapeutics, Inc. Second Amended and Restated Bylaws (Adopted March 31, 2023) Section 1 - Stockholders
12/34/56
EX-3.1
from 8-K 5 pages Fifth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 17 pages Mersana Therapeutics, Inc. Amended and Restated Bylaws Section 1 - Stockholders
12/34/56
EX-3.1
from 8-K 8 pages Fifth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.5
from S-1 14 pages Nanopharma Corp. By-Laws
12/34/56
EX-3.4
from S-1 16 pages Mersana Therapeutics, Inc. Amended and Restated Bylaws Section 1 - Stockholders
12/34/56
EX-3.3
from S-1 3 pages Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.2
from S-1 22 pages Fourth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.1
from S-1 8 pages Fifth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.5
from DRS 14 pages Nanopharma Corp. By-Laws
12/34/56
EX-3.3
from DRS 3 pages Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56
EX-3.2
from DRS 22 pages Fourth Amended and Restated Certificate of Incorporation of Mersana Therapeutics, Inc
12/34/56